A Perspective on Efflux Transport Proteins in the Liver

Overview

Journal Clin Pharmacol Ther

Publisher Wiley

Specialty Pharmacology

Date 2012 Sep 6

PMID 22948894

Citations 28

Authors

K Kock

K L R Brouwer

Affiliations

Soon will be listed here.

Abstract

Detailed knowledge regarding the influence of hepatic transport proteins on drug disposition has advanced at a rapid pace over the past decade. Efflux transport proteins located in the basolateral and apical (canalicular) membranes of hepatocytes play an important role in the hepatic elimination of many endogenous and exogenous compounds, including drugs and metabolites. This review focuses on the role of these efflux transporters in hepatic drug excretion. The impact of these proteins as underlying factors for disease is highlighted, and the importance of hepatic efflux proteins in the efficacy and toxicity of drugs is discussed. In addition, a brief overview of methodology to evaluate the function of hepatic efflux transport proteins is provided. Current challenges in predicting the impact of altered efflux protein function on systemic, intestinal, and hepatocyte exposure to drugs and metabolites are highlighted.

Citing Articles

Multidrug Resistance-Associated Proteins 3 and 5 Play a Role in the Hepatic Transport of Mercuric Conjugates of Glutathione.

Galiciolli M, Joshee L, Oliveira C, Barkin J, Bridges C Int J Mol Sci. 2025; 26(3).

PMID: 39940963 PMC: 11818351. DOI: 10.3390/ijms26031194.

Does Bisphenol A (BPA) Exposure Cause Human Diseases?.

Stein T Biomedicines. 2025; 12(12.

PMID: 39767585 PMC: 11727305. DOI: 10.3390/biomedicines12122678.

Overcoming Challenges in Small-Molecule Drug Bioavailability: A Review of Key Factors and Approaches.

Wu K, Kwon S, Zhou X, Fuller C, Wang X, Vadgama J Int J Mol Sci. 2024; 25(23.

PMID: 39684832 PMC: 11642056. DOI: 10.3390/ijms252313121.

Impact of pregnancy related hormones on drug metabolizing enzyme and transport protein concentrations in human hepatocytes.

Fashe M, Fallon J, Miner T, Tiley J, Smith P, Lee C Front Pharmacol. 2022; 13:1004010.

PMID: 36210832 PMC: 9532936. DOI: 10.3389/fphar.2022.1004010.

Inhibition of canalicular and sinusoidal taurocholate efflux by cholestatic drugs in human hepatoma HepaRG cells.

Le Vee M, Moreau A, Jouan E, Denizot C, Parmentier Y, Fardel O Biopharm Drug Dispos. 2022; 43(6):265-271.

PMID: 36195987 PMC: 10092305. DOI: 10.1002/bdd.2333.

References

Pawlikowska L, Strautnieks S, Jankowska I, Czubkowski P, Emerick K, Antoniou A . Differences in presentation and progression between severe FIC1 and BSEP deficiencies. J Hepatol. 2010; 53(1):170-8. PMC: 3042805. DOI: 10.1016/j.jhep.2010.01.034. View

Sugiyama Y, Kato Y, Chu X . Multiplicity of biliary excretion mechanisms for the camptothecin derivative irinotecan (CPT-11), its metabolite SN-38, and its glucuronide: role of canalicular multispecific organic anion transporter and P-glycoprotein. Cancer Chemother Pharmacol. 1998; 42 Suppl:S44-9. DOI: 10.1007/s002800051078. View

Yang J, Lee P, Hutchinson I, Pravica V, Shah T, Min D . Genetic polymorphisms of MRP2 and UGT2B7 and gastrointestinal symptoms in renal transplant recipients taking mycophenolic acid. Ther Drug Monit. 2009; 31(5):542-8. DOI: 10.1097/FTD.0b013e3181b1dd5e. View

Dubin I, Johnson F . Chronic idiopathic jaundice with unidentified pigment in liver cells; a new clinicopathologic entity with a report of 12 cases. Medicine (Baltimore). 1954; 33(3):155-97. DOI: 10.1097/00005792-195409000-00001. View

Ohmann E, Burckart G, Brooks M, Chen Y, Pravica V, Girnita D . Genetic polymorphisms influence mycophenolate mofetil-related adverse events in pediatric heart transplant patients. J Heart Lung Transplant. 2010; 29(5):509-16. DOI: 10.1016/j.healun.2009.11.602. View

Fujimori S, Gudis K, Takahashi Y, Seo T, Yamada Y, Ehara A . Distribution of small intestinal mucosal injuries as a result of NSAID administration. Eur J Clin Invest. 2010; 40(6):504-10. DOI: 10.1111/j.1365-2362.2010.02290.x. View

Bowalgaha K, Miners J . The glucuronidation of mycophenolic acid by human liver, kidney and jejunum microsomes. Br J Clin Pharmacol. 2001; 52(5):605-9. PMC: 2014615. DOI: 10.1046/j.0306-5251.2001.01487.x. View

Hesselink D, Van Hest R, Mathot R, Bonthuis F, Weimar W, de Bruin R . Cyclosporine interacts with mycophenolic acid by inhibiting the multidrug resistance-associated protein 2. Am J Transplant. 2005; 5(5):987-94. DOI: 10.1046/j.1600-6143.2005.00779.x. View

Stieger B, ONeill B, Meier P . ATP-dependent bile-salt transport in canalicular rat liver plasma-membrane vesicles. Biochem J. 1992; 284 ( Pt 1):67-74. PMC: 1132698. DOI: 10.1042/bj2840067. View

10.

Reuter B, Davies N, Wallace J . Nonsteroidal anti-inflammatory drug enteropathy in rats: role of permeability, bacteria, and enterohepatic circulation. Gastroenterology. 1997; 112(1):109-17. DOI: 10.1016/s0016-5085(97)70225-7. View

11.

Wallace J, Syer S, Denou E, Palma G, Vong L, McKnight W . Proton pump inhibitors exacerbate NSAID-induced small intestinal injury by inducing dysbiosis. Gastroenterology. 2011; 141(4):1314-22, 1322.e1-5. DOI: 10.1053/j.gastro.2011.06.075. View

12.

Lee J, Leslie E, Zamek-Gliszczynski M, Brouwer K . Modulation of trabectedin (ET-743) hepatobiliary disposition by multidrug resistance-associated proteins (Mrps) may prevent hepatotoxicity. Toxicol Appl Pharmacol. 2008; 228(1):17-23. PMC: 2572823. DOI: 10.1016/j.taap.2007.11.020. View

13.

Strautnieks S, Bull L, Knisely A, Kocoshis S, Dahl N, Arnell H . A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis. Nat Genet. 1998; 20(3):233-8. DOI: 10.1038/3034. View

14.

Zelcer N, Saeki T, Reid G, Beijnen J, Borst P . Characterization of drug transport by the human multidrug resistance protein 3 (ABCC3). J Biol Chem. 2001; 276(49):46400-7. DOI: 10.1074/jbc.M107041200. View

15.

Cui Y, Konig J, Keppler D . Vectorial transport by double-transfected cells expressing the human uptake transporter SLC21A8 and the apical export pump ABCC2. Mol Pharmacol. 2001; 60(5):934-43. DOI: 10.1124/mol.60.5.934. View

16.

Pang K, Maeng H, Fan J . Interplay of transporters and enzymes in drug and metabolite processing. Mol Pharm. 2009; 6(6):1734-55. DOI: 10.1021/mp900258z. View

17.

Boelsterli U, Ramirez-Alcantara V . NSAID acyl glucuronides and enteropathy. Curr Drug Metab. 2011; 12(3):245-52. DOI: 10.2174/138920011795101877. View

18.

Childs S, Yeh R, Georges E, Ling V . Identification of a sister gene to P-glycoprotein. Cancer Res. 1995; 55(10):2029-34. View

19.

Daly A, Aithal G, Leathart J, Swainsbury R, Dang T, Day C . Genetic susceptibility to diclofenac-induced hepatotoxicity: contribution of UGT2B7, CYP2C8, and ABCC2 genotypes. Gastroenterology. 2007; 132(1):272-81. DOI: 10.1053/j.gastro.2006.11.023. View

20.

Sasaki T, Hirota T, Ryokai Y, Kobayashi D, Kimura M, Irie S . Systematic screening of human ABCC3 polymorphisms and their effects on MRP3 expression and function. Drug Metab Pharmacokinet. 2011; 26(4):374-86. DOI: 10.2133/dmpk.dmpk-10-rg-103. View